These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 19854263

  • 1. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
    Matron C, Chakravarti A, Allaeys I, Poubelle PE.
    Free Radic Biol Med; 2010 Jan 15; 48(2):207-15. PubMed ID: 19854263
    [Abstract] [Full Text] [Related]

  • 2. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
    Fu H, Karlsson J, Björkman L, Stenfeldt AL, Karlsson A, Bylund J, Dahlgren C.
    J Immunol Methods; 2008 Feb 29; 331(1-2):50-8. PubMed ID: 18166194
    [Abstract] [Full Text] [Related]

  • 3. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1050-6. PubMed ID: 17692291
    [Abstract] [Full Text] [Related]

  • 4. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H, Bylund J, Karlsson A, Pellmé S, Dahlgren C.
    Immunology; 2004 Jun 01; 112(2):201-10. PubMed ID: 15147563
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
    Karlsson J, Fu H, Boulay F, Dahlgren C, Hellstrand K, Movitz C.
    J Leukoc Biol; 2005 Sep 01; 78(3):762-71. PubMed ID: 15951351
    [Abstract] [Full Text] [Related]

  • 6. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
    Forsman H, Dahlgren C.
    Scand J Immunol; 2009 Oct 01; 70(4):396-402. PubMed ID: 19751275
    [Abstract] [Full Text] [Related]

  • 7. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.
    Mol Pharmacol; 2003 Sep 01; 64(3):721-30. PubMed ID: 12920210
    [Abstract] [Full Text] [Related]

  • 8. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J, Stenfeldt AL, Rabiet MJ, Bylund J, Forsman HF, Dahlgren C.
    Cell Calcium; 2009 May 01; 45(5):431-8. PubMed ID: 19282028
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T, Hazeki K, Hazeki O, Okada T, Ui M.
    Biochem J; 1999 Jan 15; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [Abstract] [Full Text] [Related]

  • 10. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
    Fu H, Björkman L, Janmey P, Karlsson A, Karlsson J, Movitz C, Dahlgren C.
    BMC Cell Biol; 2004 Dec 29; 5(1):50. PubMed ID: 15625007
    [Abstract] [Full Text] [Related]

  • 11. Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met.
    Betten A, Dahlgren C, Hermodsson S, Hellstrand K.
    Scand J Immunol; 2003 Sep 29; 58(3):321-6. PubMed ID: 12950678
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant human granulocyte/macrophage colony-stimulating factor on neutrophil superoxide production.
    Schultz RM.
    Immunopharmacol Immunotoxicol; 1991 Sep 29; 13(1-2):183-98. PubMed ID: 1663143
    [Abstract] [Full Text] [Related]

  • 13. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
    Lee HY, Bae YS.
    Biochem Biophys Res Commun; 2008 May 02; 369(2):573-8. PubMed ID: 18294454
    [Abstract] [Full Text] [Related]

  • 14. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
    Dahlgren C, Christophe T, Boulay F, Madianos PN, Rabiet MJ, Karlsson A.
    Blood; 2000 Mar 01; 95(5):1810-8. PubMed ID: 10688842
    [Abstract] [Full Text] [Related]

  • 15. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
    Eckert RE, Jones SL.
    J Leukoc Biol; 2007 Nov 01; 82(5):1311-21. PubMed ID: 17684042
    [Abstract] [Full Text] [Related]

  • 16. Characterisation of degranulation and phagocytic capacity of a human neutrophilic cellular model, PLB-985 cells.
    Pivot-Pajot C, Chouinard FC, El Azreq MA, Harbour D, Bourgoin SG.
    Immunobiology; 2010 Nov 01; 215(1):38-52. PubMed ID: 19250699
    [Abstract] [Full Text] [Related]

  • 17. Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha involves regulation at a post-cell surface receptor level. Enhancement of the effect of agents which directly activate G proteins.
    McColl SR, Beauseigle D, Gilbert C, Naccache PH.
    J Immunol; 1990 Nov 01; 145(9):3047-53. PubMed ID: 2170531
    [Abstract] [Full Text] [Related]

  • 18. The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways.
    Boxio R, Bossenmeyer-Pourié C, Vanderesse R, Dournon C, Nüsse O.
    Scand J Immunol; 2005 Aug 01; 62(2):140-7. PubMed ID: 16101820
    [Abstract] [Full Text] [Related]

  • 19. A novel nonpeptide ligand for formyl peptide receptor-like 1.
    Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, Ye RD.
    Mol Pharmacol; 2004 Nov 01; 66(5):1213-22. PubMed ID: 15308762
    [Abstract] [Full Text] [Related]

  • 20. Calcium channel blockers suppress cytokine-induced activation of human neutrophils.
    Shima E, Katsube M, Kato T, Kitagawa M, Hato F, Hino M, Takahashi T, Fujita H, Kitagawa S.
    Am J Hypertens; 2008 Jan 01; 21(1):78-84. PubMed ID: 18091748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.